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Objective: The aim of this study was to analyze the evolution from 1997 to 2009 of survival without significant
(moderate and severe) bronchopulmonary dysplasia (SWsBPD) in extremely-low-birth-weight (ELBW) infants and to
determine the influence of changes in resuscitation, nutrition and mechanical ventilation on the survival rate.
Study design: In this study, 415 premature infants with birth weights below 1000 g (ELBW) were divided into three
chronological subgroups: 1997 to 2000 (n = 65), 2001 to 2005 (n = 178) and 2006 to 2009 (n = 172).
Between 1997 and 2000, respiratory resuscitation in the delivery room was performed via a bag and mask (AmbuW,
Ballerup, Sweden) with 40-50% oxygen. If this procedure was not effective, oral endotracheal intubation was always
performed. Pulse oximetry was never used. Starting on January 1, 2001, a change in the delivery room respiratory
policy was established for ELBW infants. Oxygenation and heart rate were monitored using a pulse oximeter
(NellcorW) attached to the newborn’s right hand. If resuscitation was required, ventilation was performed using a
face mask, and intermittent positive pressure was controlled via a ventilator (Babylog2, Drägger). In 2001, a policy of
aggressive nutrition was also initiated with the early provision of parenteral amino acids. We used standardized
parenteral nutrition to feed ELBW infants during the first 12–24 hours of life. Lipids were given on the first day. The
glucose concentration administered was increased by 1 mg/kg/minute each day until levels reached 8 mg/kg/
minute. Enteral nutrition was started with trophic feeding of milk. In 2006, volume guarantee treatment was
instituted and administered together with synchronized intermittent mandatory ventilation (SIMV + VG). The
complications of prematurity were treated similarly throughout the study period. Patent ductus arteriosus was only
treated when hemodynamic repercussion. Surgical closure of the patent ductus arteriosus was performed when
two courses of indomethacin or ibuprofen were not sufficient to close it.
Mild BPD were defined by a supplemental oxygen requirement at 28 days of life and moderate BPD if breathing
room air or a need for <30% oxygen at 36 weeks postmenstrual age or discharge from the NICU, whichever came
first. Severe BPD was defined by a supplemental oxygen requirement at 28 days of life and a need for greater than
or equal to 30% oxygen use and/or positive pressure support (IPPV or nCPAP) at 36 weeks postmenstrual age or
discharge, whichever came first. Moderate and severe BPD have been considered together as “significant BPD”. The
goal of pulse oximetry was to maintain a hemoglobin saturation of between 88% and 93%. Patients were
considered to not need oxygen supplementation when it could be permanently withdrawn. The distribution of the
variables was not normal based on a Kolmogorov-Smirnov test (p< 0.05 in all cases). Therefore, quantitative
variables were expressed as the median and interquartile range (IQR; 25th-75th percentile). Statistical analysis of the* Correspondence: fbotet@clinic.ub.es
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analysis was used to analyze qualitative variables. Potential confounding variables were those possibly related to
BPD in survivors (p between 0.05 and 0.3 in univariate analysis). Logistic regression analysis was performed with
variables related to BPD in survivors (p< 0.05) and potential confounding variables. The forward stepwise method
adjusted for confounding factors was used to select the variables, and the enter method using selected variables
was used to obtain the odds ratios.
Results and conclusion: There was an increase in the rate of SWsBPD (1997 to 2000: 58.5%; 2001 to 2005: 74.2%;
and 2006 to 2009: 75.0%; p = 0.032). In survivors, the occurrence of significant BPD decreased after 2001 (9.5% vs.
2.3%; p = 0.013). The factors associated with improved SWsBPD were delivery by caesarean section, a reduced
endotracheal intubation rate and a reduced duration of mechanical ventilation.While the mortality of ELBW infants
has not changed since 2001, the frequency of SWsBPD has significantly increased (75.0%) in association with
increased caesarean sections and reductions in the endotracheal intubation rate, as well as the duration of
mechanical ventilation.
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Bronchopulmonary dysplasia (BPD) is the most common
cause of chronic lung disease and is one of the most im-
portant sequelae of premature birth. BPD was originally
described in children born slightly premature with se-
vere respiratory distress syndrome (RDS) who had been
exposed to aggressive mechanical ventilation and high
concentrations of inspired oxygen. In recent years, this
phenotype has been replaced by a new form of BPD that
occurs in infants who are much less mature, often
resulting in less iatrogenic injury. In this form of BPD,
the immature lung fails to reach its full structural com-
plexity, resulting in a global reduction in the surface
available for gas exchange [1-5].
We hypothesized that survival without significant (mod-
erate and severe) BPD (SWsBPD) would be higher among
a group of ELBW infants born between 1997 and 2009
and would be related to the primary changes that occurred
during this period of time, namely, a new delivery room
respiratory resuscitation strategy, an aggressive nutrition
regimen and a new mode of mechanical ventilation.
Patients and methods
The study group included all ELBW infants (less than
1000 g) born in our hospital between January 1997 and
December 2009 (n = 415). The neonates were divided
into three chronological subgroups according to birth
date: group 1, 1997 to 2000 (n = 65); group 2, 2001 to
2005 (n = 178); and group 3, 2006 to 2009 (n = 172). The
study was approved by the Ethics Committee in Neonat-
ology of the Hospital Clínic de Barcelona.
Between 1997 and 2000, respiratory resuscitation in the
delivery room was performed via a bag and mask (AmbuW,
Ballerup, Sweden) with 40-50% oxygen. If this procedure
was not effective, oral endotracheal intubation was always
performed before chest compressions were applied. Pulse
oximetry was never used. Starting on January 1, 2001, achange in the delivery room respiratory policy was estab-
lished for ELBW infants. Oxygenation and heart rate were
monitored using a pulse oximeter (NellcorW) attached to
the newborn’s right hand. If resuscitation was required, ven-
tilation was performed using a face mask, and intermittent
positive pressure was controlled via a ventilator (Babylog2,
Drägger), which applied a peak inspiratory pressure (PIP)
ranging from 20 to 25 cmH2O, a positive end-expiratory
pressure (PEEP) of 6 cmH2O, a rate of 50 breaths per mi-
nute, and an inspiratory time of 0.4 seconds (inspiratory/
expiratory ratio =1/2). Oxygen concentrations were
adjusted (Babymix2, Drägger) to maintain the oxygen satur-
ation between 85% and 90%. Respiratory support after
stabilization, during transport to the Neonatal Intensive
Care Unit (NICU), and upon admission to the NICU was
provided with continuous positive airway pressure (CPAP).
In 2001, a policy of aggressive nutrition [6,7] was also
initiated with the early provision of parenteral amino acids
[8,9]. All preterm infants were fed according to our proto-
col [10]. We used standardized parenteral nutrition (1.5 g/
kg/day of protein and 5 mg/kg/minute of glucose in
70 mL/kg/day of water) to feed ELBW infants during the
first 12–24 hours of life. Fluids were set at 70 mL/kg/day
on the first day of life and then increased to 10–20 mL/kg/
day until they reached 160 mL/kg/day on the 7th or 8th days
of life. Lipids were given at 1 g/kg/day on the first day.
Amino acid and lipid intake were increased by 0.5 g/kg/day
until they reached 3 g/kg/day and 2.5 g/kg/day, respectively.
The glucose concentration administered was increased by
1 mg/kg/minute each day until levels reached 8 mg/kg/mi-
nute. Insulin was added when serum glucose levels
were >150 mg/dL, with glycosuria or serum glucose
levels >180 mg/dL. Enteral nutrition was started
with trophic feeding of milk at 4, 8, 16 and 32 mL/kg/day
on days 1, 2, 3 and 4 of life, respectively; thereafter, enteral
milk was increased by 20 mL/kg/day every day until levels
reached 160 mL/kg/day on the 10th day of life. Preterm
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ning on the first day of life, and if expressed breast milk
was given, 3% fortification was added when half of the total
enteral dose target was reached.
In 2006, volume guarantee treatment was instituted and
administered together with synchronized intermittent
mandatory ventilation (SIMV+VG). To achieve good al-
veolar recruitment, a PEEP between 5 and 7 cmH2O was
applied. The initial target tidal volume is set between 4
and 5 mL/kg. Larger tidal volumes of up to 6 mL/kg may
be required in extremely premature infants.
The complications of prematurity were treated simi-
larly throughout the study period. Patent ductus arterio-
sus was only treated when hemodynamically significant
(need for oxygen or CPAP/VPPI, severe pulmonary
hypertension). Surgical closure of the patent ductus
arteriosus was performed when two courses of indo-
methacin or ibuprofen were not sufficient to close it.
Mild BPD were defined by a supplemental oxygen re-
quirement at 28 days of life and moderate BPD if breath-
ing room air or a need for <30% oxygen at 36 weeks
postmenstrual age or discharge from the NICU,Table 1 Characteristics of the ELBW infants in this study
Group 1 Gr
(1997–2000) (20
(N= 65) (N
Gestational age (w) 27.0 (26–28) 27
Birth weight (g) 814 (680–935) 80
IUGR 24 (38.1%) 6
Multiple gestation 21 (32.3%) 6
Male gender 26 (40%) 9
Chorioamnionitis 5 (7.7%) 3
Antibiotics (mother) 40 (62.5%) 10
Prenatal steroids 52 (81.3%) 16
Cesarean section 44 (67.7%) 12
Apgar at 1 min ≤3 19 (30.2%) 2
Apgar at 5 min ≤6 11 (16.9%) 2
Umbilical artery pH 7.23 (7.13-7.30) 7.2
Resuscitation:
- Not 9performed 9 (13.8%) 3
- Mask/IPPV + PEEP 6 (9.2%) 6
- ETI 44 (67.7%) 6
- ETI + ChC+ E 6 (9.2%)
Mechanical ventilation
- ET intubation 56 (86.2%) 12
- Duration (days) 4 (1–9)
IUGR: intrauterine growth restriction; ETI: endotracheal intubation; ChC: chest comp
positive end-expiratory pressure.
Median (IQR: 25th-75th percentile), number (%).
Kruskal-Wallis or chi-square test.whichever came first. Severe BPD was defined by a sup-
plemental oxygen requirement at 28 days of life and a
need for greater than or equal to 30% oxygen use and/or
positive pressure support (IPPV or nCPAP) at 36 weeks
postmenstrual age or discharge, whichever came first
[2]. Moderate and severe BPD have been considered to-
gether as “significant BPD”. The goal of pulse oximetry
was to maintain a hemoglobin saturation of between
88% and 93%. Patients were considered to not need oxy-
gen supplementation when it could be permanently
withdrawn. In groups 1 and 2, the classification was
established retrospectively.
The distribution of the variables was not normal based
on a Kolmogorov-Smirnov test (p< 0.05 in all cases).
Therefore, quantitative variables were expressed as the
median and interquartile range (IQR; 25th-75th percent-
ile). Statistical analysis of the data was performed using
nonparametric techniques (Kruskal-Wallis test and
Mann–Whitney U test). A chi-square analysis was used
to analyze qualitative variables. Potential confounding
variables were those possibly related to BPD in survivors
(p between 0.05 and 0.3 in univariate analysis). Logisticoup 2 Group 3 p-value*
01–2005) (2006–2009)
= 178) (N= 172)
.0 (25.6-29.0) 26.9 (25.7-28.8) 0.988
0 (700–915) 800 (700–900) 0.903
3 (36.0%) 62 (39.0%) 0.773
0 (33.7%) 69 (40.1%) 0.180
2 (51.7%) 80 (46.5%) 0.684
1 (17.4%) 45 (26.2%) 0.004
4 (62.3%) 101 (62.7%) 0.956
5 (96.5%) 157 (91.8%) 0.097
1 (68.8%) 101 (59.1%) 0.098
6 (14.6%) 21 (12.3%) 0.004
5 (14.3%) 25 (15.2%) 0.836
7 (7.21-7.32) 7.27 (7.17-7.32) 0.019
9 (21.9%) 25 (14.5%) 0.133
5 (36.5%) 70 (40.7%) <0.001
7 (37.6%) 70 (40.7%) <0.001
7 (3.9%) 7 (4.1%) 0.195
1 (68.0%) 123 (71.5%) 0.143
2 (0–5) 2 (0–7) 0.005
ression; E: epinephrine; IPPV: intermittent positive pressure ventilation; PEEP:
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to BPD in survivors (p< 0.05) and potential confounding
variables. The forward stepwise method adjusted for
confounding factors was used to select the variables, and
the enter method using selected variables was used to
obtain the odds ratios.Results
The characteristics of the newborns in the three groups
are shown in Table 1. The initial severity of the infants’
clinical conditions in the three groups was similar, with-
out significant differences in the CRIB score or the inci-
dence of respiratory distress syndrome (Table 2). The
morbidities studied, including those related to infections,
necrotizing enterocolitis, intraventricular hemorrhage,
and periventricular leukomalacia, were also similar be-
tween groups. The differences between the SWsBPD
group and the group comprising deceased or surviving
infants with significant BPD are shown in Table 3. Logis-
tic regression analysis adjusted for confounding factors
(Table 4) confirmed that the factors significantly and in-
dependently associated with an increase in SWsBPD
included birth by cesarean section from a singleTable 2 Morbidity and mortality in ELBW infants
Group 1 G
(1997–2000) (2
(N= 65) (N
CRIB 3 (1–8)
RDS 36 (55.4%)
Sepsis 28 (43.1%)
NEC 6 (9.2%)
IVH 18 (27.7%)
- Grades III/IV 11 (16.9%)
PVLM 1 (4.5%)
PDA 17 (26.2%)
- Surgical closure 1 (1.5%)
Parenteral nutrition (day) 13 (7–20)
Formula feed 24 (45.3%)
Mortality** 23 (35.4%)
SWsBPD 38 (58.5%) 1
In survivors: n = 42 n
Mild BPD 8 (19.0%)
Moderate or severe BPD 4 (9.5%) 3
Weight at discharge (g) 2148 (2100–2250) 20
Length of stay (days) 83 (64–102)
Weight gain (g/kg/day) 16 (14–18)
CRIB: clinical risk index for babies; RDS: respiratory distress syndrome; NEC: necrotiz
leukomalacia; PDA: patent ductus arteriosus; SWsBPD: survival without significant b
Median (IQR: 25th-75th percentile), number (%).
* Kruskal-Wallis or chi-square test; ** All deaths occurred in the NICU.pregnancy without the need for deep resuscitation,
higher birth weight, little or no need for mechanical ven-
tilation, and the absence of grade III-IV intraventricular
hemorrhage and severe arterial hypotension.Discussion
During the period studied, the data showed a trend to-
ward a decrease in the death rate of ELBW infants, al-
though this trend was not significant. Mild forms of
BPD affected approximately 30% of the preterm infants
during the study, whereas the incidence of severe forms
of BPD declined, and the BPD-free survival rate
increased from 58% (1997–2000) to 75% (2001–2009).
Chorioamnionitis and patent ductus arteriosus have
been diagnosed more frequently in recent years. This in-
crease in diagnosis may be due to an improvement in
the accuracy of amniotic liquid analysis or heart ultra-
sound techniques, respectively. Extubation was per-
formed earlier in recent years than it had been in the
past, and PDA was more frequent. However, this was
not followed by an increase in the diagnosis of BPD
throughout the study period; in fact, the opposite trend
was observed.roup 2 Group 3 p-value*
001–2005) (2006–2009)
= 178) (N= 172)
4 (2–7) 4 (2–8) 0.722
99 (55.6%) 103 (59.9%) 0.432
85 (47.8%) 65 (37.8%) 0.215
12 (6.7%) 12 (7.0%) 0.644
36 (20.2%) 43 (25.0%) 0.999
16 (9.0%) 18 (10.5%) 0.307
5 (5.6%) 4 (2.3%) 0.245
56 (31.5%) 75 (43.6%) 0.004
12 (6.7%) 18 (10.5%) 0.058
9 (6–13) 8 (6–12) 0.009
40 (25.2%) 17 (11.1%) <0.001
43 (24.2%) 40 (23.3%) 0.102
32 (74.2%) 129 (75.0%) 0.032
= 135 n= 132
34 (25.2%) 39 (29.5%) 0.378
(2.2%) 3 (2.3%) 0.046
60 (1900–2160) 2013 (1900–2193) <0.001
70 (59–83) 71 (59–85) 0.007
17 (15–19) 17 (15–19) 0.233
ing enterocolitis; IVH: peri-intraventricular hemorrhage; PVLM: periventricular
ronchopulmonary dysplasia.
Table 3 Differences between survivors without significant BPD and deceased or surviving infants with significant BPD
SWsBPD Deceased/Significant BPD p-value*
(n = 299) (n = 116)
Year of birth 0.032
- 1997–2000 38 (58.5%) 27 (41.5%)
- 2001–2005 132 (74.2%) 46 (25.8%)
- 2006–2009 129 (75.0%) 43 (25.0%)
Gestational age (w) 27.6 (26.1-29.4) 25.4 (24.4-27.0) <0.001
Birth weight (g) 850 (750–935) 680 (589–780) <0.001
IUGR 112 (38.5%) 37 (34.9%) 0.515
Multiple gestation 102 (34.1%) 48 (41.4%) 0.167
Male gender 135 (45.2%) 63 (54.3%) 0.094
Chorioamnionitis 48 (16.1%) 33 (28.4%) 0.004
Antibiotics (mother) 167 (59.6%) 78 (69.6%) 0.065
Prenatal steroids 277 (95.2%) 97 (84.3%) <0.001
Cesarean section 213 (72.0%) 53 (45.7%) <0.001
Apgar at 1 minute ≤3 29 (9.7%) 37 (32.5%) <0.001
Apgar at 5 minutes ≤6 29 (9.7%) 32 (28.3%) <0.001
Umbilical artery pH 7.26 (7.17-7.31) 7.29 (7.19-7.32) 0.165
Resuscitation <0.001
- Not performed 67 (22.4%) 6 (5.2%)
- Mask/IPPV + PEEP 121 (40.5%) 20 (17.2%)
- ET intubation 102 (34.1%) 79 (68.1%)
- ET Intubation +
chest compression +
epinephrine 9 (3.0%) 11 (9.5%)
CRIB 4 (1–6) 9 (7–13) <0.001
RDS 146 (48.8%) 92 (79.3%) <0.001
Mechanical ventilation 184 (61.5%) 116 (100%) <0.001
Sepsis 124 (41.5%) 54 (46.6%) 0.349
NEC 17 (5.7%) 13 (11.2%) 0.052
IVH 52 (17.4%) 45 (38.8%) <0.001
- Grades III/IV 11 (3.7%) 34 (29.3%) <0.001
PVLM 6 (3.1%) 4 (4.5%) 0.536
PDA 105 (35.1%) 43 (37.1%) 0.710
- Surgical closure 25 (8.4%) 6 (5.2%) 0.268
Severe arterial
hypotension 10 (3.4%) 30 (26.1%) <0.001
CRIB: clinical risk index for babies; IUGR: intrauterine growth restriction; ET: endotracheal; RDS: respiratory distress syndrome; NEC: necrotizing enterocolitis; IVH:
peri-intraventricular hemorrhage; PEEP: positive end expiratory pressure; PVLM: periventricular leukomalacia; PDA: patent ductus arteriosus; SWsBPD: survival
without significant BPD.
Median (IQR: 25th-75th percentile), number (%).
* Mann–Whitney U or chi-square test.
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tion strategy was introduced in 2001. With the increased
use of CPAP since 2001, the need for endotracheal in-
tubation and ventilation in the delivery room has
diminished. The duration of mechanical ventilation hasalso decreased. The use of mechanical ventilation in
premature infants may result in barotrauma, volu-
trauma and BPD [11]. Early surfactant therapy and the
initiation of nasal CPAP in these infants significantly re-
duce the need for mechanical ventilation and the
Table 4 Odds ratios for significant associations between
survival without significant BPD and related variables in
ELBW infants
OR (95% CI) p-value
Survival without significant BPD
- Cesarean section 2.44 (1.38-4.33) 0.002
- Multiple gestation 0.46 (0.25-083) 0.011
- Level of resuscitation 0.36 (0.25-0.50) <0.001
- Birth weight (1000 grams) 1.72 (1.51-1.96) <0.001
- Mechanical ventilation (days) 0.97 (0.94-0.99) 0.015
- Intraventricular hemorrhage, grades III-IV 0.10 (0.04-0.23) <0.001
- Severe arterial hypotension 0.17 (0.07-0.41) 0.001
Sample size: Included 409/415 newborns (99%); R2 = 0.646.
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included data from centers with a relatively recent his-
tory of using CPAP, a trend toward a lower rate of BPD
was found in the CPAP group compared with the MV
group. Many observational studies that compared pri-
mary CPAP and MV support found a decreased risk of
developing BPD when CPAP was used as the primary
means of ventilator support [14,15]. Together, these
studies support a strong correlation between the use of
MV and the development of BPD. The use of nasal
CPAP appears to be a successful strategy for avoiding
the need for mechanical ventilation in some infants, with
the presumptive benefit of decreasing the risk of BPD
[16]. The Columbian approach of using nasal CPAP in
the delivery room in premature infants has resulted in a
significant reduction in BPD. The recommended ap-
proach for ELBW infants with respiratory distress is to
start CPAP in the delivery room immediately after
stabilization, with intubation performed only for surfac-
tant administration. In addition, adjustment of the sup-
plemental oxygen intake is recommended to maintain
pulse oximetry saturations between 85% and 93% in
infants with a gestational age of less than 32 weeks
[17-20]. In the SUPPORT trial, which involved ELBW
infants, there was no significant difference between a
strategy involving early CPAP and limited ventilation
compared to one involving early intubation and surfac-
tant administration within one hour after birth with re-
spect to the rate of the composite primary outcome of
death or BPD [21,22]. In secondary analyses, the CPAP
strategy resulted in a lower rate of intubation than early
surfactant treatment, both in the delivery room and in
the NICU, which is similar to our findings. These data
support the consideration of CPAP as an alternative to
routine intubation and surfactant administration in pre-
term infants [23].
Other strategies that may be effective in reducing lung
injury and subsequent BPD include the prevention ofinfection, early implementation of aggressive nutrition
and treatment of a patent ductus arteriosus [24]. We
began a policy of aggressive nutrition in 2001, with a sig-
nificant decrease in the duration of parenteral nutrition
and an increase in the amount of mother’s milk adminis-
tered. These facts could have influenced the reduction of
BPD incidence and length of stay with low weight at dis-
charge, although the higher weight gain observed
throughout the hospital stay did not represent a signifi-
cant difference with low weight gain. However, Wilson
[25] reported that sick VLBW infants allocated to an ag-
gressive nutritional regimen exhibited better growth but
similar survival and a similar incidence of BPD com-
pared with a control group.
In 2006, we initiated a new mode of ventilation,
namely, volume-guarantee (VG) ventilation, which
reduces large tidal volumes, decreases the incidence of
inadvertent hyperventilation, reduces the duration of
mechanical ventilation and pneumothorax [26], and
reduces proinflammatory cytokine levels [11]. Further-
more, VG decreases the expression of early inflamma-
tory markers to a greater extent than high-frequency
oscillatory ventilation [27]. Therefore, VG may decrease
the incidence of BPD; however, in our study, there was
no reduction in the BPD rate after 2006, although the
duration of mechanical ventilation remained low.
Cesarean section was associated with elective pre-
term delivery, and vaginal delivery was associated with
emergency deliveries and chorioamnionitis. For this
reason, preterms born by cesarean section have better
prognoses and typically do not require aggressive pre-
natal support [28].
This study has some limitations. The data were col-
lected from a database but were introduced prospect-
ively during the study period. The most important
changes during this period were the introduction of re-
spiratory assistance in the delivery room, the initiation
of a protocol of aggressive nutrition and the practice of
VG ventilation. However, other changes could have
influenced the neonatal prognosis. The strength of the
study was the use of a large number of ELBW infants
(415) who were born at the same hospital, thus yielding
similar baseline characteristics.
Conclusions
Over the past 13 years, the morbidity of ELBW infants has
not changed; however, the rate of SWsBPD has increased
(75.0%). Delivery by caesarean section and reductions in
the endotracheal intubation rate and the duration of mech-
anical ventilation are protective factors that could reduce
the frequency of SWsBPD in these infants.
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